Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 153 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52
Warning: DOMDocument::loadHTML(): htmlParseEntityRef: no name in Entity, line: 153 in /home/dev/public_html/wp-content/themes/pru2.0/amp/single.php on line 52
(Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The news site hosting this press release is not associated with QYResearch. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product, research, doctor, or service.)
The 2019–20 coronavirus pandemic is an ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the course of treatment, some traditional Chinese medicines and their prescriptions play an important role in clinical practice.
Clinical observation shows that the total effective rate of TCM is more than 90%.
Traditional Chinese medicine may effectively relieve symptoms, reduce the development from light and ordinary type to heavy type, improve the cure rate, reduce the rate of disease death, and promote the recovery of the convalescent population.
Get PDF report template @ https://www.qyresearch.com/sample-form/form/1663842/global-taditional-chinese-medicine-tcm-for-covid-19-market
The Major Traditional Chinese Medicine (TCM) for COVID-19 Player in the Market
Yiling Pharmaceutical
Tianjin Chase Sun Pharmaceutical
Sunflower
Guizhou Yibai Pharmaceutical
Beijing Juxiechang Pharmaceutical
Jiren Pharmaceutical Group
Qingfeng Pharmaceutical Group
Southwest Pharmaceutical
Jiuzhitang
China Beijing Tong Ren Tang Group Co., Ltd.
Jiangsu Jichuan Holding Group Co., Ltd.
The number of confirmed cases of novel coronavirus in the United States has surged, making it the epicenter of the global outbreak.The total number of tests in the United States is high, but still insufficient, and the number of confirmed cases in the United States will continue to grow rapidly in the future. Italy and Spain, the worst affected countries in Europe, are close to turning points, and France, Germany and Britain are expected to reach them in mid-to-late April.
Table2. COVID-19 Conditon by Country/Region
| Country/Region | Confirmed Cases | Total Deaths | Total Tested |
| US | 459,687 | 40,682 | 3,882,002 |
| Spain | 198,674 | 20,453 | |
| Italy | 178,972 | 23,660 | |
| France | 154,098 | 19,744 | |
| Germany | 145,742 | 4,642 | |
| United Kingdom | 121,173 | 16,060 | |
| Turkey | 86,306 | 2,017 | |
| China | 83,817 | 4,636 | |
| India | 17,615 | 559 | |
| Japan | 10,797 | 236 |
Source: Secondary Sources, Expert Interviews and QYResearch, 2020
Based on our recent survey, we have several different scenarios about the Traditional Chinese Medicine growth rate for 2020. The probable scenario is expected to grow by a 23.2% in 2020 and the revenue will be *** in 2020 from US$ *** million in 2019. The market size of Traditional Chinese Medicine will reach US$ *** in 2026, with a CAGR of 23.5% from 2020 to 2026.
Figure 1. Global Traditional Chinese Medicine Market Size (Value), (US$ Million), 2015 VS 2020 VS 2026
Source: Secondary Sources, Expert Interviews and QYResearch, 2020
At present, the emerging artificial intelligence, data mining and other new and high technologies are also promoting the digital transformation of the TCM industry, especially in the inheritance of TCM experience, the improvement of TCM health management efficiency and the construction of an intelligent platform for TCM diagnosis.In addition, the emergence of new techniques and equipment in the production field is also promoting the rapid development of TCM processing industry.
Figure 2. Technology and Equipment in Process of Traditional Chinese Medicine
Source: Secondary Sources, Expert Interviews and QYResearch, 2020
Figure 3. China TCM Output Value and Growth Rate, 2019 (US$ Million)
Source: Secondary Sources, Expert Interviews and QYResearch, 2020
The quality of Chinese medicinal materials is uneven, the upstream of the industrial chain of Chinese medicinal materials has too many links in the circulation of raw materials, and it is difficult to trace the source of Chinese medicinal materials. Some persistent diseases such as irregular planting, heavy metal pollution residue and unstable drug effect still exist in various places. In the future, the standardized planting system of Chinese medicinal materials and the traceability system of industrial chain still have broad development space.
“Internet + traditional Chinese medicine” can not only reduce the intermediate links, but also form a digital management system through the precise guidance of e-commerce.
With the continuous iterative development of new tools and new technologies, the industry system of Chinese medicinal materials will get a higher degree of innovation through the innovative model of “Internet + Chinese medicinal materials”, standardized planting, authentic source tracing, supply and demand information matching, financial assistance and other means.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Traditional Chinese Medicine (TCM) for COVID-19 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Traditional Chinese Medicine (TCM) for COVID-19 market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Traditional Chinese Medicine (TCM) for COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Traditional Chinese Medicine (TCM) for COVID-19 market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Traditional Chinese Medicine (TCM) for COVID-19 market, covering important regions, viz, China.. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Traditional Chinese Medicine (TCM) for COVID-19 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Taditional Chinese Medicine (TCM) for COVID-19 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Taditional Chinese Medicine (TCM) for COVID-19 market.
The following manufacturers are covered in this report:
- Yiling Pharmaceutical
- Tianjin Chase Sun Pharmaceutical
- Sunflower
- Guizhou Yibai Pharmaceutical
- Beijing Juxiechang Pharmaceutical
- Jiren Pharmaceutical Group
- Qingfeng Pharmaceutical Group
- Southwest Pharmaceutical
- Jiuzhitang
- China Beijing Tong Ren Tang Group Co., Ltd.
- Jiangsu Jichuan Holding Group Co., Ltd.
Taditional Chinese Medicine (TCM) for COVID-19 Breakdown Data by Type
- Lianhua Qingwen Capsule
- Jinhua Qinggan Granules
- Xuebijing Injection
- TCM Prescription
- Other
Taditional Chinese Medicine (TCM) for COVID-19 Breakdown Data by Application
- Hospital
- Clinic
- Other
Get Customized Report in your Inbox within 24 hours @ https://www.qyresearch.com/customize-request/form/1663842/global-taditional-chinese-medicine-tcm-for-covid-19-market
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
About QY Research
QY Research is a leading global market research and consulting company. Established in 2007 in Beijing, China, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue models and make them successful. We are globally recognized for our expansive portfolio of services.
